WHAT WE DO
WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $3 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
 
OUR AREAS
INVESTMENT MANAGEMENT

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

m&a AND STRATEGIC ADVISORY

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.  

INVESTMENT BANKING

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.  

institutional sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

equity research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

EQUITY Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

PRESS RELEASES

VIEW ALL

WBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea Biopharmaceuticals

WBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under…
CONTINUE READING

WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and…
CONTINUE READING

WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference

Today WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference…
CONTINUE READING

OPINIONS & FEATURES

VIEW ALL

Analyst Interview: As Cancer Immunotherapy Turns 125, WBB Securities’ Steve Brozak Ponders What Investors Can Expect from Biotech Next

Steve Brozak sees a bubble getting larger, and he is anticipating the time when biotech stocks pull back to take…
CONTINUE READING

M&A Mania Infects Generic Drug Companies

There are very few assurances in life, but in the field of generic pharmaceuticals, there are three certainties we are…
CONTINUE READING

Can The Apple Watch Really Keep The Doctor Away?

At a little after 12:00 AM Pacific Time consumers will be able to pre-order the Apple Watch online for delivery…
CONTINUE READING